Janika Josephin Schulze

Title: Janika Josephin Schulze: Innovator in Immune Cell Identification

Introduction

Janika Josephin Schulze is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of immunology, particularly in the identification of immune cells. Her innovative work focuses on the epigenetic markers that can distinguish specific immune cell types.

Latest Patents

Janika holds a patent for her invention titled "Endosialin (CD248) as epigenetic marker for the identification of immune cells, in particular naïve CD8+ T-cells." This patent describes a method for identifying specific immune cells by analyzing the methylation status of the endosialin (CD248) gene region. The method allows for the identification of naïve CD8+ T-cells on an epigenetic level, distinguishing them from other blood or immune cells in complex samples. This innovative approach provides an improved method for quantifying naïve CD8+ T-cells, which can be performed with or without a purification step.

Career Highlights

Janika is currently employed at Precision for Medicine GmbH, where she continues her research and development in the field of immunology. Her work has garnered attention for its potential applications in medical diagnostics and therapeutic strategies.

Collaborations

Janika collaborates with Sven Olek, contributing to advancements in their shared field of research. Their partnership enhances the scope and impact of their work in immune cell identification.

Conclusion

Janika Josephin Schulze is a trailblazer in the field of immunology, with her innovative patent paving the way for new methods of identifying immune cells. Her contributions are poised to make a significant impact on medical research and diagnostics.